{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:12:14Z","timestamp":1760170334972},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s10741-006-9193-5","type":"journal-article","created":{"date-parts":[[2006,7,5]],"date-time":"2006-07-05T06:06:24Z","timestamp":1152079584000},"page":"57-64","source":"Crossref","is-referenced-by-count":21,"title":["Metabolic and immunologic derangements in cardiac cachexia: where to from here?"],"prefix":"10.1007","volume":"11","author":[{"given":"Sabine","family":"Strassburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"9363","key":"9193_CR1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","volume":"361","author":"SD Anker","year":"2003","unstructured":"Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003;361(9363):1077\u201383.","journal-title":"Lancet"},{"issue":"9058","key":"9193_CR2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","volume":"349","author":"SD Anker","year":"1997","unstructured":"Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349(9058):1050\u201353","journal-title":"Lancet"},{"issue":"2","key":"9193_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2004.01.014","volume":"99","author":"L Castillo-Martinez","year":"2005","unstructured":"Castillo-Martinez L, Orea-Tejeda A, Rosales MT, et al. Anthropometric variables and physical activity as predictors of cardiac cachexia. Int J Cardiol 2005;99(2):239\u201345","journal-title":"Int J Cardiol"},{"issue":"3","key":"9193_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3317\/jraas.2003.020","volume":"4","author":"T Murray-Thomas","year":"2003","unstructured":"Murray-Thomas T, Cowie MR. Epidemiology and clinical aspects of congestive heart failure. J Renin Angiotensin Aldosterone Syst 2003;4(3):131\u20136","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"Suppl 2","key":"9193_CR5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1136\/hrt.72.2_Suppl.S3","volume":"72","author":"WB Kannel","year":"1994","unstructured":"Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994;72 Suppl 2:S3\u20139","journal-title":"Br Heart J"},{"issue":"3","key":"9193_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","volume":"8","author":"C Deans","year":"2005","unstructured":"Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 2005;8(3):265\u20139","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"9193_CR7","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1097\/01.ju.0000121440.82581.d3","volume":"171","author":"HL Kim","year":"2004","unstructured":"Kim HL, Han KR, Zisman A, Figlin RA, Belldegrun AS. Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma. J Urol 2004;171(5):1810\u201313","journal-title":"J Urol"},{"issue":"8","key":"9193_CR8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/rmed.2002.1322","volume":"96","author":"G Pitsiou","year":"2002","unstructured":"Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, Patakas D. Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 2002;96(8):594\u20138","journal-title":"Respir Med"},{"issue":"3","key":"9193_CR9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1183\/09031936.02.00532002","volume":"20","author":"E Prescott","year":"2002","unstructured":"Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002;20(3):539\u201344","journal-title":"Eur Respir J"},{"issue":"2","key":"9193_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1378\/chest.113.2.421","volume":"113","author":"E Casalino","year":"1998","unstructured":"Casalino E, Mendoza-Sassi G, Wolff M, et al. Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest 1998;113(2):421\u20139","journal-title":"Chest"},{"issue":"3","key":"9193_CR11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcn\/50.3.444","volume":"50","author":"DP Kotler","year":"1989","unstructured":"Kotler DP, Tierney AR, Wang J, Pierson RN, Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50(3):444\u20137","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"9193_CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-5273(02)00245-0","volume":"85","author":"S von Haehling","year":"2002","unstructured":"von Haehling S, Genth-Zotz S, Anker SD, Volk HD. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol 2002;85(1):173\u201383","journal-title":"Int J Cardiol"},{"issue":"1","key":"9193_CR13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1022103222857","volume":"8","author":"S von Haehling","year":"2003","unstructured":"von Haehling S, Anker SD, Bassenge E. Statins and the role of nitric oxide in chronic heart failure. Heart Fail Rev 2003;8(1):99\u2013106","journal-title":"Heart Fail Rev"},{"issue":"5","key":"9193_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cardfail.2003.12.009","volume":"10","author":"M Cicoira","year":"2004","unstructured":"Cicoira M, Davos CH, Francis DP, et al. Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. J Card Fail 2004;10(5):421\u20136","journal-title":"J Card Fail"},{"issue":"9","key":"9193_CR15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/euhj.1998.1446","volume":"20","author":"SD Anker","year":"1999","unstructured":"Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20(9):683\u201393","journal-title":"Eur Heart J"},{"issue":"4","key":"9193_CR16","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.85.4.1364","volume":"85","author":"DM Mancini","year":"1992","unstructured":"Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85(4):1364\u201373","journal-title":"Circulation"},{"issue":"7","key":"9193_CR17","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0735-1097(97)00381-1","volume":"30","author":"D Harrington","year":"1997","unstructured":"Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997;30(7):1758\u201364","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"9193_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0002-9149(98)00927-8","volume":"83","author":"SD Anker","year":"1999","unstructured":"Anker SD, Clark AL, Teixeira MM, Hellewell PG, Coats AJ. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999;83(4):612-615, A610","journal-title":"Am J Cardiol"},{"issue":"6","key":"9193_CR19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0002-9149(81)90333-7","volume":"48","author":"DS Goldstein","year":"1981","unstructured":"Goldstein DS. Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. Am J Cardiol 1981;48(6):1147\u201354","journal-title":"Am J Cardiol"},{"issue":"2","key":"9193_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.CIR.80.2.299","volume":"80","author":"IS Anand","year":"1989","unstructured":"Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989;80(2):299\u2013305","journal-title":"Circulation"},{"issue":"10","key":"9193_CR21","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1161\/01.RES.0000102404.81461.25","volume":"93","author":"RA Ahokas","year":"2003","unstructured":"Ahokas RA, Warrington KJ, Gerling IC, et al. Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. Circ Res 2003;93(10):e124\u2013135","journal-title":"Circ Res"},{"issue":"7","key":"9193_CR22","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.febslet.2005.02.017","volume":"579","author":"E Barreiro","year":"2005","unstructured":"Barreiro E, de la Puente B, Busquets S, Lopez-Soriano FJ, Gea J, Argiles JM. Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats. FEBS Lett 2005;579(7):1646\u201352","journal-title":"FEBS Lett"},{"issue":"5","key":"9193_CR23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2004.12.041","volume":"120","author":"H Kamata","year":"2005","unstructured":"Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005;120(5):649\u201361","journal-title":"Cell"},{"issue":"1","key":"9193_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-5273(02)00535-1","volume":"90","author":"GS Filippatos","year":"2003","unstructured":"Filippatos GS, Kanatselos C, Manolatos DD, et al. Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia. Int J Cardiol 2003;90(1):107\u201313","journal-title":"Int J Cardiol"},{"issue":"3","key":"9193_CR25","first-page":"209","volume":"3","author":"MJ Tisdale","year":"2005","unstructured":"Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol 2005;3(3):209\u201317","journal-title":"J Support Oncol"},{"issue":"7","key":"9193_CR26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.bjc.6602780","volume":"93","author":"J Khal","year":"2005","unstructured":"Khal J, Wyke SM, Russell ST, Hine AV, Tisdale MJ. Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. Br J Cancer 2005;93(7):774\u201380","journal-title":"Br J Cancer"},{"issue":"2-3","key":"9193_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0946-672X(01)80046-8","volume":"15","author":"M Rukgauer","year":"2001","unstructured":"Rukgauer M, Neugebauer RJ, Plecko T. The relation between selenium, zinc and copper concentration and the trace element dependent antioxidative status. J Trace Elem Med Biol 2001;15(2-3):73\u20138","journal-title":"J Trace Elem Med Biol"},{"issue":"6","key":"9193_CR28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/153537020322800604","volume":"228","author":"JH Kramer","year":"2003","unstructured":"Kramer JH, Mak IT, Phillips TM, Weglicki WB. Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med (Maywood) 2003;228(6):665\u201373","journal-title":"Exp Biol Med (Maywood)"},{"issue":"7","key":"9193_CR29","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0735-1097(01)01227-X","volume":"37","author":"KK Witte","year":"2001","unstructured":"Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol 2001;37(7):1765\u201374","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9193_CR30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0735-1097(00)00745-2","volume":"36","author":"R Sharma","year":"2000","unstructured":"Sharma R, Rauchhaus M, Ponikowski PP, et al. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2000;36(2):523\u20138","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"9193_CR31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/07853890410017467","volume":"36","author":"SD Anker","year":"2004","unstructured":"Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med 2004;36(7):518\u201329","journal-title":"Ann Med"},{"issue":"4","key":"9193_CR32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"323","author":"B Levine","year":"1990","unstructured":"Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323(4):236\u201341","journal-title":"N Engl J Med"},{"issue":"2","key":"9193_CR33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/hrt.70.2.141","volume":"70","author":"DP Dutka","year":"1993","unstructured":"Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumour necrosis factor alpha in severe congestive cardiac failure. Br Heart J 1993;70(2):141\u20133","journal-title":"Br Heart J"},{"issue":"5","key":"9193_CR34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/hrt.66.5.356","volume":"66","author":"J McMurray","year":"1991","unstructured":"McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in \u201ccachectic\u201d patients with severe chronic heart failure. Br Heart J 1991;66(5):356\u20138","journal-title":"Br Heart J"},{"issue":"1","key":"9193_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","volume":"85","author":"SD Anker","year":"2002","unstructured":"Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002;85(1):51\u201366","journal-title":"Int J Cardiol"},{"issue":"15","key":"9193_CR36","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","volume":"107","author":"SD Anker","year":"2003","unstructured":"Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107(15):1991\u20137","journal-title":"Circulation"},{"issue":"12","key":"9193_CR37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ehj.2004.04.023","volume":"25","author":"R Sharma","year":"2004","unstructured":"Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJ, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 2004;25(12):1021\u20138","journal-title":"Eur Heart J"},{"issue":"1","key":"9193_CR38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0167-5273(02)00233-4","volume":"85","author":"SD Anker","year":"2002","unstructured":"Anker SD. Cachexia: time to receive more attention. Int J Cardiol 2002;85(1):5\u20136","journal-title":"Int J Cardiol"},{"issue":"11","key":"9193_CR39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-121-11-199412010-00006","volume":"121","author":"ET Poehlman","year":"1994","unstructured":"Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 1994;121(11):860\u20132","journal-title":"Ann Intern Med"},{"issue":"14","key":"9193_CR40","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0002-9149(96)00176-2","volume":"77","author":"TO Obisesan","year":"1996","unstructured":"Obisesan TO, Toth MJ, Donaldson K, et al. Energy expenditure and symptom severity in men with heart failure. Am J Cardiol 1996;77(14):1250\u20132","journal-title":"Am J Cardiol"},{"issue":"10","key":"9193_CR41","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0002-9149(97)00159-8","volume":"79","author":"SD Anker","year":"1997","unstructured":"Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997;79(10):1426\u201330","journal-title":"Am J Cardiol"},{"issue":"11","key":"9193_CR42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0002-9149(02)02839-4","volume":"90","author":"S Genth-Zotz","year":"2002","unstructured":"Genth-Zotz S, von Haehling S, Bolger AP, et al. Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol 2002;90(11):1226\u201330","journal-title":"Am J Cardiol"},{"issue":"1-2","key":"9193_CR43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-005-2733-9","volume":"278","author":"JJ Chmielinska","year":"2005","unstructured":"Chmielinska JJ, Tejero-Taldo MI, Mak IT, Weglicki WB. Intestinal and cardiac inflammatory response shows enhanced endotoxin receptor (CD14) expression in magnesium deficiency. Mol Cell Biochem 2005;278(1-2):53\u20137","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"9193_CR44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrg862","volume":"3","author":"GS Barsh","year":"2002","unstructured":"Barsh GS, Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 2002;3(8):589\u2013600","journal-title":"Nat Rev Genet"},{"issue":"4-5","key":"9193_CR45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.26719\/2001.7.4-5.697","volume":"7","author":"EM el-Bindary","year":"2001","unstructured":"el-Bindary EM, Darwish AZ. New biochemical markers in chronic heart failure. East Mediterr Health J 2001;7(4-5):697\u2013706","journal-title":"East Mediterr Health J"},{"issue":"10","key":"9193_CR46","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1053\/euhj.1998.1045","volume":"19","author":"F Leyva","year":"1998","unstructured":"Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ. Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J 1998;19(10):1547\u201351","journal-title":"Eur Heart J"},{"issue":"3","key":"9193_CR47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.82.3.352","volume":"82","author":"DR Murdoch","year":"1999","unstructured":"Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJ. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart 1999;82(3):352\u20136","journal-title":"Heart"},{"issue":"5","key":"9193_CR48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn1455","volume":"8","author":"RD Cone","year":"2005","unstructured":"Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005;8(5):571\u20138","journal-title":"Nat Neurosci"},{"issue":"2","key":"9193_CR49","first-page":"774","volume":"9","author":"Y Shimizu","year":"2003","unstructured":"Shimizu Y, Nagaya N, Isobe T, et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003;9(2):774\u20138","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9193_CR50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0735-1097(98)00226-5","volume":"32","author":"J Niebauer","year":"1998","unstructured":"Niebauer J, Pflaum CD, Clark AL, et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998;32(2):393\u20137","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"9193_CR51","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","volume":"96","author":"SD Anker","year":"1997","unstructured":"Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96(2):526\u201334","journal-title":"Circulation"},{"issue":"5 Pt 1","key":"9193_CR52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1667\/0033-7587(2001)156[0447:TPICBA]2.0.CO;2","volume":"156","author":"F Pajonk","year":"2001","unstructured":"Pajonk F, McBride WH. The proteasome in cancer biology and treatment. Radiat Res 2001;156(5 Pt 1):447\u201359","journal-title":"Radiat Res"},{"issue":"5","key":"9193_CR53","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ygeno.2004.07.013","volume":"84","author":"D Kuninger","year":"2004","unstructured":"Kuninger D, Kuzmickas R, Peng B, Pintar JE, Rotwein P. Gene discovery by microarray: identification of novel genes induced during growth factor-mediated muscle cell survival and differentiation. Genomics 2004;84(5):876\u201389","journal-title":"Genomics"},{"issue":"2","key":"9193_CR54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/endo.143.2.8648","volume":"143","author":"S Adi","year":"2002","unstructured":"Adi S, Bin-Abbas B, Wu NY, Rosenthal SM. Early stimulation and late inhibition of extracellular signal-regulated kinase 1\/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation. Endocrinology 2002;143(2):511\u201316","journal-title":"Endocrinology"},{"issue":"6914","key":"9193_CR55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich S, Krag TO, Barton ER, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002;420(6914):418\u201321","journal-title":"Nature"},{"issue":"9A","key":"9193_CR56","doi-asserted-by":"crossref","first-page":"35B","DOI":"10.1016\/j.amjcard.2004.01.004","volume":"93","author":"MB Fowler","year":"2004","unstructured":"Fowler MB. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure. Am J Cardiol 2004;93(9A):35B-39B","journal-title":"Am J Cardiol"},{"issue":"22","key":"9193_CR57","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344(22):1651\u20138","journal-title":"N Engl J Med"},{"issue":"9169","key":"9193_CR58","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"Effect of metoprolol CR\/XL in chronic heart failure","year":"1999","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353(9169):2001\u20137","journal-title":"Lancet"},{"issue":"9146","key":"9193_CR59","first-page":"9","volume":"353","author":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II)","year":"1999","unstructured":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353(9146):9\u201313","journal-title":"a randomised trial. Lancet"},{"issue":"6","key":"9193_CR60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1071-9164(03)00582-7","volume":"9","author":"K Hryniewicz","year":"2003","unstructured":"Hryniewicz K, Androne AS, Hudaihed A, Katz SD. Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. J Card Fail 2003;9(6):464\u20138","journal-title":"J Card Fail"},{"issue":"3","key":"9193_CR61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2005.01.061","volume":"106","author":"M Lainscak","year":"2006","unstructured":"Lainscak M, Keber I, Anker SD. Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study. Int J Cardiol 2006;106(3):319\u201322","journal-title":"Int J Cardiol"},{"issue":"1","key":"9193_CR62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0167-5273(99)00008-X","volume":"69","author":"L Liu","year":"1999","unstructured":"Liu L, Zhao SP. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy. Int J Cardiol 1999;69(1):77\u201382","journal-title":"Int J Cardiol"},{"issue":"7","key":"9193_CR63","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0735-1097(99)00495-7","volume":"34","author":"L Gullestad","year":"1999","unstructured":"Gullestad L, Aukrust P, Ueland T, et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 1999;34(7):2061\u20137","journal-title":"J Am Coll Cardiol"},{"key":"9193_CR64","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/00005344-200000006-00019","volume":"36","author":"N Mabuchi","year":"2000","unstructured":"Mabuchi N, Tsutamoto T, Kinoshita M. Therapeutic use of dopamine and beta-blockers modulates plasma interleukin-6 levels in patients with congestive heart failure. J Cardiovasc Pharmacol 2000;36 Suppl 2:S87\u201391","journal-title":"J Cardiovasc Pharmacol"},{"issue":"17","key":"9193_CR65","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa010342","volume":"345","author":"DN Herndon","year":"2001","unstructured":"Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001;345(17):1223\u20139","journal-title":"N Engl J Med"},{"issue":"3","key":"9193_CR66","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0959-8049(99)00273-7","volume":"36","author":"A Hyltander","year":"2000","unstructured":"Hyltander A, Daneryd P, Sandstrom R, Korner U, Lundholm K. Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. Eur J Cancer 2000;36(3):330\u20134","journal-title":"Eur J Cancer"},{"issue":"3","key":"9193_CR67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0008-6363(03)00251-7","volume":"58","author":"A Cittadini","year":"2003","unstructured":"Cittadini A, Monti MG, Isgaard J, et al. Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure. Cardiovasc Res 2003;58(3):555\u201364","journal-title":"Cardiovasc Res"},{"issue":"10","key":"9193_CR68","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1440-1681.2003.03906.x","volume":"30","author":"JG Mill","year":"2003","unstructured":"Mill JG, Milanez Mda C, de Resende MM, Gomes Mda G, Leite CM. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats. Clin Exp Pharmacol Physiol 2003;30(10):739\u201344","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"10","key":"9193_CR69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341(10):709\u201317","journal-title":"N Engl J Med"},{"issue":"25","key":"9193_CR70","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1161\/hc5001.101749","volume":"104","author":"S Fichtlscherer","year":"2001","unstructured":"Fichtlscherer S, Rossig L, Breuer S, Vasa M, Dimmeler S, Zeiher AM. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 2001;104(25):3023\u20135","journal-title":"Circulation"},{"issue":"25","key":"9193_CR71","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1161\/01.CIR.99.25.3224","volume":"99","author":"A Deswal","year":"1999","unstructured":"Deswal A, Bozkurt B, Seta Y, et al. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 1999;99(25):3224\u20136","journal-title":"Circulation"},{"issue":"8","key":"9193_CR72","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.CIR.103.8.1044","volume":"103","author":"B Bozkurt","year":"2001","unstructured":"Bozkurt B, Torre-Amione G, Warren MS, et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 2001;103(8):1044\u20137","journal-title":"Circulation"},{"issue":"13","key":"9193_CR73","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","volume":"109","author":"DL Mann","year":"2004","unstructured":"Mann DL, McMurray JJ, Packer M, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004;109(13):1594\u2013602","journal-title":"Circulation"},{"issue":"25","key":"9193_CR74","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003;107(25):3133\u201340","journal-title":"Circulation"},{"issue":"2\u20133","key":"9193_CR75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","volume":"86","author":"SD Anker","year":"2002","unstructured":"Anker SD, Coats AJ. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 2002;86(2\u20133):123\u201330","journal-title":"Int J Cardiol"},{"issue":"6","key":"9193_CR76","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00005344-200412000-00007","volume":"44","author":"AR Kherani","year":"2004","unstructured":"Kherani AR, Moss GW, Zhou H, et al. Macrophage inhibitor, semapimod, reduces tumor necrosis factor-alpha in myocardium in a rat model of ischemic heart failure. J Cardiovasc Pharmacol 2004;44(6):665\u201371","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"9193_CR77","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI118398","volume":"97","author":"T Tsujinaka","year":"1996","unstructured":"Tsujinaka T, Fujita J, Ebisui C, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 1996;97(1):244\u20139","journal-title":"J Clin Invest"},{"issue":"21","key":"9193_CR78","first-page":"5602","volume":"54","author":"K Lundholm","year":"1994","unstructured":"Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994;54(21):5602\u20136","journal-title":"Cancer Res"},{"issue":"1","key":"9193_CR79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10557-005-6893-3","volume":"19","author":"J Zhang","year":"2005","unstructured":"Zhang J, Cheng X, Liao YH, et al. Simvastatin Regulates Myocardial Cytokine Expression and Improves Ventricular Remodeling in Rats after Acute Myocardial Infarction. Cardiovasc Drugs Ther 2005;19(1):13\u201321","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"9193_CR80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","volume":"108","author":"K Node","year":"2003","unstructured":"Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003;108(7):839\u201343","journal-title":"Circulation"},{"issue":"6","key":"9193_CR81","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1939-1676.1998.tb02148.x","volume":"12","author":"LM Freeman","year":"1998","unstructured":"Freeman LM, Rush JE, Kehayias JJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 1998;12(6):440\u20138","journal-title":"J Vet Intern Med"},{"issue":"1","key":"9193_CR82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjc.6690654","volume":"81","author":"MD Barber","year":"1999","unstructured":"Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999;81(1):80\u20136","journal-title":"Br J Cancer"},{"issue":"21","key":"9193_CR83","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/eurheartj\/ehi442","volume":"26","author":"KK Witte","year":"2005","unstructured":"Witte KK, Nikitin NP, Parker AC, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005;26(21):2238\u201344","journal-title":"Eur Heart J"},{"issue":"24","key":"9193_CR84","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1053\/euhj.2001.2693","volume":"22","author":"AL Clark","year":"2001","unstructured":"Clark AL, Loebe M, Potapov EV, et al. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J 2001;22(24):2275\u201383","journal-title":"Eur Heart J"},{"issue":"11","key":"9193_CR85","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.healun.2005.02.003","volume":"24","author":"D Habedank","year":"2005","unstructured":"Habedank D, Hummel M, Hetzer R, Anker S. Reversibility of cardiac cachexia after heart transplantation. J Heart Lung Transplant 2005;24(11):1757\u201362","journal-title":"J Heart Lung Transplant"},{"issue":"8681","key":"9193_CR86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0140-6736(90)90536-E","volume":"335","author":"AJ Coats","year":"1990","unstructured":"Coats AJ, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 1990;335(8681):63\u20136","journal-title":"Lancet"},{"issue":"1","key":"9193_CR87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-5273(02)00243-7","volume":"85","author":"PC Schulze","year":"2002","unstructured":"Schulze PC, Gielen S, Schuler G, Hambrecht R. Chronic heart failure and skeletal muscle catabolism: effects of exercise training. Int J Cardiol 2002;85(1):141\u20139","journal-title":"Int J Cardiol"},{"issue":"6","key":"9193_CR88","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/01.CIR.85.6.2119","volume":"85","author":"AJ Coats","year":"1992","unstructured":"Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992;85(6):2119\u201331","journal-title":"Circulation"},{"issue":"4","key":"9193_CR89","first-page":"1432","volume":"61","author":"DL Marks","year":"2001","unstructured":"Marks DL, Ling N, Cone RD. Role of the central melanocortin system in cachexia. Cancer Res 2001;61(4):1432\u20138","journal-title":"Cancer Res"},{"issue":"8","key":"9193_CR90","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1210\/endo.142.8.8324","volume":"142","author":"BE Wisse","year":"2001","unstructured":"Wisse BE, Frayo RS, Schwartz MW, Cummings DE. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 2001;142(8):3292\u2013301","journal-title":"Endocrinology"},{"key":"9193_CR91","doi-asserted-by":"crossref","unstructured":"Bocchi E, Moura L, Guimaraes G, Conceicao Souza GE, Ramires JA. Beneficial effects of high doses of growth hormone in the introduction and optimization of medical treatment in decompensated congestive heart failure. Int J Cardiol 2005","DOI":"10.1016\/j.ijcard.2005.06.068"},{"issue":"6762","key":"9193_CR92","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402(6762):656\u201360","journal-title":"Nature"},{"issue":"6806","key":"9193_CR93","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","volume":"407","author":"M Tschop","year":"2000","unstructured":"Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407(6806):908\u201313","journal-title":"Nature"},{"issue":"2\u20133","key":"9193_CR94","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-0115(03)00117-4","volume":"114","author":"N Nagaya","year":"2003","unstructured":"Nagaya N, Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regul Pept 2003;114(2\u20133):71\u20137","journal-title":"Regul Pept"},{"issue":"2","key":"9193_CR95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1471-4892(03)00013-4","volume":"3","author":"N Nagaya","year":"2003","unstructured":"Nagaya N, Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 2003;3(2):146\u201351","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"9193_CR96","doi-asserted-by":"crossref","first-page":"E1007","DOI":"10.1152\/ajpendo.00109.2005","volume":"289","author":"M Granado","year":"2005","unstructured":"Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Am J Physiol Endocrinol Metab 2005;289(6):E1007\u201314","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"9193_CR97","doi-asserted-by":"crossref","first-page":"H1643","DOI":"10.1152\/ajpheart.01042.2004","volume":"289","author":"XB Xu","year":"2005","unstructured":"Xu XB, Pang JJ, Cao JM, et al. GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. Am J Physiol Heart Circ Physiol 2005;289(4):H1643\u201351","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"9193_CR98","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-291X(02)03028-0","volume":"301","author":"T Hanada","year":"2003","unstructured":"Hanada T, Toshinai K, Kajimura N, et al. Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 2003;301(2):275\u20139","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"9193_CR99","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1210\/jc.2005-2304","volume":"91","author":"D Miljic","year":"2006","unstructured":"Miljic D, Pekic S, Djurovic M, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 2006;91(4):1491\u20135","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"9193_CR100","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","volume":"350","author":"M Schuelke","year":"2004","unstructured":"Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350(26):2682\u20138","journal-title":"N Engl J Med"},{"issue":"1","key":"9193_CR101","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0167-5273(02)00253-X","volume":"85","author":"N Rosenthal","year":"2002","unstructured":"Rosenthal N, Musaro A. Gene therapy for cardiac cachexia? Int J Cardiol 2002;85(1):185\u201391","journal-title":"Int J Cardiol"},{"issue":"2","key":"9193_CR102","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI22324","volume":"115","author":"YH Song","year":"2005","unstructured":"Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 2005;115(2):451\u20138","journal-title":"J Clin Invest"},{"issue":"26","key":"9193_CR103","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1073\/pnas.95.26.15603","volume":"95","author":"ER Barton-Davis","year":"1998","unstructured":"Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 1998;95(26):15603\u20137","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5356","key":"9193_CR104","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.279.5356.1528","volume":"279","author":"G Ferrari","year":"1998","unstructured":"Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279(5356):1528\u201330","journal-title":"Science"},{"issue":"6751","key":"9193_CR105","first-page":"390","volume":"401","author":"E Gussoni","year":"1999","unstructured":"Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401(6751):390\u20134","journal-title":"Nature"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-006-9193-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-006-9193-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-006-9193-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-006-9193-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T22:09:44Z","timestamp":1652566184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-006-9193-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["9193"],"URL":"https:\/\/doi.org\/10.1007\/s10741-006-9193-5","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}